Its downregulation has been shown to decrease breast and lung cancer cell clonogenicity and anchorage-independent growth, whereas the loss of imprinting at the H19 locus, and resulting overexpression, has been described in many other cancers, including esophagus, colon, liver and bladder [296]. This evidence concerns the gene H19 and lung cancer.